CytoDyn Inc. (CYDY): Price and Financial Metrics

CytoDyn Inc. (CYDY): $0.12

0.00 (-3.08%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add CYDY to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#356 of 385

in industry

CYDY Price/Volume Stats

Current price $0.12 52-week high $0.42
Prev. close $0.12 52-week low $0.11
Day low $0.12 Volume 1,858,000
Day high $0.12 Avg. volume 2,571,837
50-day MA $0.14 Dividend yield N/A
200-day MA $0.15 Market Cap 141.81M

CYDY Stock Price Chart Interactive Chart >


CytoDyn Inc. (CYDY) Company Bio


CytoDyn Inc., a late-stage biotechnology company, focuses on the clinical development and commercialization of humanized monoclonal antibodies to treat human immunodeficiency virus (HIV) infection. Its lead product is PRO 140, a therapeutic anti-viral agent, which is in Phase IIb extension study for HIV as monotherapy, rollover study for HIV as a combination therapy, Phase IIb/III investigative trial for HIV, Phase Ib/II trial for triple-negative breast cancer, and Phase II trial for graft-versus-host disease. CytoDyn Inc. has strategic agreement with Samsung BioLogics Co. Ltd. for the clinical and commercial manufacturing of leronlimab. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.


CYDY Latest News Stream


Event/Time News Detail
Loading, please wait...

CYDY Latest Social Stream


Loading social stream, please wait...

View Full CYDY Social Stream

CYDY Price Returns

1-mo -14.71%
3-mo -7.55%
6-mo -49.81%
1-year -33.44%
3-year -90.55%
5-year -61.29%
YTD -38.46%
2023 -13.33%
2022 -77.24%
2021 -81.66%
2020 439.00%
2019 112.77%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!